Product Information
ISRADIPINE 2.5 MG CAPSULE is a generic product labeled by Elite Laboratories, Inc., priced at $1.5006 per EA under NDC 64850091001. Its NADAC has been published 28 times since Dec 17, 2025.
Strength
2.5 mg/1
Manufacturer
Elite Laboratories, Inc.NDC
64850091001
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ISRADIPINEApproval Type
Generic (ANDA)
FDA Application
ANDA077169On Market Since
12/28/2022
Pharmacological Classes
Price Statistics
The NADAC for ISRADIPINE 2.5 MG CAPSULE has been published 28 times since Dec 17, 2025, and over the history we have for it it has declined 17.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.5006 per EA |
|---|---|
| All-time high | $1.8070 (Jan 14, 2026) |
| All-time low | $1.5006 (Jun 17, 2026) |
| 52-week high | $1.8070 |
| 52-week low | $1.5006 |
| Median price | $1.7395 |
| Average price | $1.7318 |
| Largest weekly change | -10.0% (Jun 17, 2026) |
| Weeks tracked | 28 |
| Tracking since | Dec 17, 2025 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ISRADIPINE 2.5 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for ISRADIPINE 2.5 MG CAPSULE, manufactured by Elite Laboratories, Inc., is $1.5006 per EA (NDC 64850091001), effective Jun 24, 2026.
How has the price of ISRADIPINE 2.5 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for ISRADIPINE 2.5 MG CAPSULE has declined 17.0%. It has been tracked across 28 weekly CMS publications since Dec 17, 2025.
What are the highest and lowest recorded NADAC prices for ISRADIPINE 2.5 MG CAPSULE?
Since Dec 17, 2025, the NADAC for ISRADIPINE 2.5 MG CAPSULE has ranged from a low of $1.5006 (Jun 17, 2026) to a high of $1.8070 (Jan 14, 2026), with a median of $1.7395 per EA.
Are there cheaper alternatives to ISRADIPINE 2.5 MG CAPSULE?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as ISRADIPINE 2.5 MG CAPSULE, but none are currently priced below it.
Who manufactures ISRADIPINE 2.5 MG CAPSULE?
ISRADIPINE 2.5 MG CAPSULE (NDC 64850091001) is labeled by Elite Laboratories, Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification